Supernus Pharmaceuticals, Inc. (SUPN)

53.87 -0.40 (-0.74%) USD  |  NASDAQ  |  Mar 06, 16:00
53.92 +0.05 (+0.09%) Pre-Market: 20:00
More

Supernus Pharmaceuticals EPS Diluted from Other Gain/Loss (Quarterly)

EPS Diluted from Other Gain/Loss (Quarterly) Chart

View EPS Diluted from Other Gain/Loss (Quarterly) for SUPN.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS Diluted from Other Gain/Loss (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

EPS Diluted from Other Gain/Loss (Quarterly) Range, Past 5 Years

View EPS Diluted from Other Gain/Loss (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted from Other Gain/Loss (Quarterly) Benchmarks

View EPS Diluted from Other Gain/Loss (Quarterly) Benchmarks
Start Trial
Biogen, Inc. --
BridgeBio Pharma, Inc. --
Corcept Therapeutics, Inc. --
Catalyst Pharmaceuticals, Inc. --
Cytokinetics, Inc. --